(All fields required)
Please enter a valid email.
Please enter your name.
What is : (So we know you are human.)
Please supply the correct answer.
The ability to pharmacologically render patients insensible to noxious stimulation using general anesthetics and sedatives represents one of the greatest discoveries in medicine. Advanced physiological monitoring and meticulous administration of modern anesthetic drugs have facilitated surgical interventions to mitigate life-threatening conditions in very young children. Moreover, sedation during mechanical ventilation and painful procedures in intensive care units has shielded neonates from the deleterious effects of pain and suffering. Accordingly, every year, millions of young children worldwide are exposed to anesthetics and sedatives to ablate the stress response to noxious stimulation and to mitigate potential, stress-related morbidity during painful procedures and imaging studies.
However, recent findings in laboratory animals have demonstrated a widespread increase in apoptotic brain cell death, an inborn cell suicide program, immediately following exposure to all currently and commonly used sedatives and anesthetics. Moreover, several preclinical studies have also observed alterations in synaptic formation and subsequent impairment in neurocognitive function. These findings in newborn animals have led to significant concerns among pediatric anesthesiologists and parents. Given the potentially serious consequences of long-term neurological sequelae following uneventful pediatric surgery with anesthesia, our research aims to clarify the underlying mechanisms and the selectivity of anesthesia-induced neurotoxicity, which will be critical for assessing human relevance of this phenomenon, and if necessary, for aiding in the development of mitigating strategies.
Along those lines, our laboratory has previously demonstrated significant differences between anesthetic effects in young children during pediatric anesthesia and those in model species, revealing a progressive lactacidosis, hypoglycemia and lethality. Moreover, our group was able to establish that neuronal degeneration during an anesthetic exposure early in life may not be necessarily linked with subsequent neurocognitive dysfunction, which has now been confirmed by other groups. To compare the effects of the three most commonly used anesthetics, Desflurane, Isoflurane and Sevoflurane, in pediatric anesthesia, we have recently established their differential potencies and have found similar neurotoxic profiles among them.
To increase our understanding of anesthesia-induced neurotoxicity and to aid in the discovery of potentially mitigating therapies, we are currently characterizing the phenomenon’s selectivity as well as examining the underlying mechanisms. Moreover, our laboratory is working on the identification of minimally invasive biomarkers for neurotoxicity. We are also participating in several clinical research studies, including a multicenter study into the long-term neurocognitive effects of surgery with anesthesia early in life (PANDA study), as well as examining the effects of surgery with anesthesia early in life on subsequent brain morphology using noninvasive magnetic resonance imaging technology.
click to enlarge
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center